A fully integrated contract genomics organization (CGO), WuXi NextCODE, has unveiled the world's first blockchain-enabled health databank — LifeCODE.ai. The launch was done alongside the user mobile application, LaiYin Tribe available on both Apple app store and Android platform, at the 2018 TechCrunch Summit in Hangzhou, China.
The LifeCODE.ai data bank uses blockchain and big data technology to bridge gaps between user health data and research institutions to provide optimal health data matching and analysis. The app innovatively applies blockchain technology to solve the legality and effectiveness of large scale health data collection. It protects individual privacy and creates data sharing value, truly realizes the property rights and asset of large health data.
LifeCODE.ai data bank is designed for both individual and enterprise users. After anonymized, the user data is encrypted and stored multiple times, ensuring that data is secure and cannot be accessed without user specific authorization. Each time the data is manipulated, it will be recorded in a non-tamperable blockchain, allowing users to trace and control data security at any time.
LifeCODE.ai And Health Data Protection
LifeCODE.ai.iIs coming at a time when there are rising concerns about the safety of patient data and the need for the industry to explore the security strength of the blockchain technology.
The Individual health data is an asset that belongs to individual. WuXi NextCODE is committed to providing superior technology and capability support for the pharmaceutical and health industry, said Mr. John Gu, Chief Digital Officer of WuXi NextCODE.
For the most part, LifeCODE.ai data bank is a major breakthrough in applying blockchain concept and technology in the field of health data management. It has the potential to help everyone securely and effectively manage and use their health data and benefit from it. WuXi NextCODE says it will continue to focus on technology evolution and explore the business applications of cutting-edge technologies such as blockchain.
It said it will also integrate more health service partners and individual users into the LifeCODE.ai ecosystem, to fully realize the data value and drive development in the larger healthcare industry.
Top industry leaders attended the launch including Dr. Chen Gang, co-founder and Chief Technology Officer of WeGene, the leading personal genome service company in China; Dr. Shi YaoZhou, Chief Operating Officer of SinoTech, a precision medicine integrated solution company; and the former Director of the Shanghai First Maternal and Infant Health Hospital, the founder of Spring Field Hospital Management, Professor Duan Tao, all attended the product launch of LifeCODE.ai data bank.